SymBio Pharmaceuticals Limited
Status: Publicly traded
Direct answer
SymBio Pharmaceuticals Limited is publicly traded on JPX under the ticker 4582.T.
SymBio Pharmaceuticals Limited, established in 2005 and headquartered in Tokyo, Japan, is a pharmaceutical company focused on the research, development, production, and commercialization of medicinal products, primarily within the oncology and hematology fields for the Japanese market. The company's leading marketed anti-cancer drug is TREAKISYM (SyB L-0501), utilized for treating non-Hodgkin's lymphoma, multiple...
Can you invest in SymBio Pharmaceuticals Limited?
Yes. SymBio Pharmaceuticals Limited is publicly traded on JPX under the ticker 4582.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for SymBio Pharmaceuticals Limited
Detailed equity research is provided by MarketSnap.